Safety and efficacy of different JAK inhibitors in the treatment of inflammatory bowel disease: a network meta-analysis

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-01-27
DOI
https://doi.org/10.3389/fphar.2025.1699928
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety and efficacy of different JAK inhibitors in the treatment of inflammatory bowel disease: a network meta-analysis

Xiaxia Du, Haidong Wu, Xuyong Chen, Yifan Guo et al.
Frontiers in Pharmacology
Inflammatory Bowel Disease
article

Safety and efficacy of different JAK inhibitors in the treatment of inflammatory bowel disease: a network meta-analysis

Xiaxia Du, Haidong Wu, Xuyong Chen, Yifan Guo, Liudan Wang, Xinpu Miao, Yongci Zhou
article en

Abstract

No abstract available for this paper.
Frontiers in PharmacologyVol. 16
Hainan General Hospital (CN), Hainan Medical University (CN)
Good health and well-being
Openalex Percentile: Top 72%
Inflammatory Bowel Disease
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Safety and efficacy of different JAK inhibitors in the treatment of inflammatory bowel disease: a network meta-analysis — Xiaxia Du, Haidong Wu, et al. · Frontiers in Pharmacology (2026) | TGRS Research Map | TGRS